MPM BioImpact portfolio
MPM BioImpact (Venture capital) is known to hold 21 companies, 7 of them startups. 5 of them are hiring now, with 55 open roles. Most of them work in Oncology Therapeutics, Prescription Drugs, Rare Disease Therapeutics.
Companies MPM BioImpact has invested in
Open roles at MPM BioImpact portfolio companies
Lead Specialist, QA ValidationElevateBio · this month
Buyer, Indirect (Contract)Umoja Biopharma · this month
Senior Specialist II, Quality Control ValidationElevateBio · this month
Production PlannerElevateBio · this month
Associate II, BiomanufacturingElevateBio · this month
Associate II, Biomanufacturing (Contract)ElevateBio · this month
Specialist I, QC Logistics (Contract)ElevateBio · this month
Scientist II, LNP, Process Development & ManufacturingElevateBio · this month
Senior Director, Financial Planning & Analysis - R&DDyne Therapeutics · this month
SEC Reporting & Technical Accounting ConsultantEntrada Therapeutics · this month
Engineer I, AutomationElevateBio · this month
Senior Clinical Operations ContractorEntrada Therapeutics · this month
Senior Administrative Assistant - US AffiliateDyne Therapeutics · this month
Executive AssistantDyne Therapeutics · this month
Senior Director, CommunicationsElevateBio · this month
Director/Sr. Director, Corporate ControllerFrontiermeds · this month
Senior Manager, Clinical Regulatory AffairsUmoja Biopharma · this month
Senior Manager, QC Technical OperationsElevateBio · this month
Sr. Clinical Trial ManagerFrontiermeds · this month
Scientist I, mRNA, Process DevelopmentElevateBio · this month
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about MPM BioImpact
How many companies has MPM BioImpact invested in?
MPM BioImpact is known to hold 21 companies: 7 startups, and 4 exits so far, read from its own portfolio page and the funding rounds that name it.
Is MPM BioImpact investing now?
MPM BioImpact has no round in the press in 12 months and no new company on its portfolio page in 90 days.
What does MPM BioImpact invest in?
The markets of the companies MPM BioImpact holds: Oncology Therapeutics (24%), Prescription Drugs (14%), Rare Disease Therapeutics (14%), Cell & Gene Therapy (14%), Custody & Fund Administration (5%).
Which MPM BioImpact portfolio companies are hiring?
5 companies MPM BioImpact holds are hiring now, with 55 open roles listed on this page.
Who does MPM BioImpact invest alongside?
The investors that hold the most companies together with MPM BioImpact: RA Capital Management, EcoR1 Capital, Sofinnova Investments, Wellington Management, DCVC.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 3
MPM BioImpact portfolio: 21 known companies. Alion, Oct 3, 2026. https://alion.io/company/mpm-bioimpact/portfolio